300+ investors in your industry, stage, and region Get
Any industry
Artificial Intelligence
Google
EdTech
Clean Energy
Retail
Enterprise Software
Local
Travel
Platforms
InsurTech
Oil and Gas
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Renewable Energy
Organic Food
Email
Fitness
CleanTech
Energy
Health Care
Machine Learning
Agriculture (AgTech)
Marketplace
Gaming
Social Network
Facebook
Blockchain
B2B
Big Data
Video Games
Education
Wellness
Medical Device
Mobile
Legal
Sports
Construction
Automotive
eSports
Hospitality
Biotechnology
Consumer
Software
Crowdfunding
Venture Capital
Social
Infrastructure
Fashion
Beauty
LGBT
Celebrity
Cannabis
Climate
Mobile Apps
Life Science
Publishing
Food and Beverage
Wine and Spirits
Real Estate
Sporting Goods
Art
Music
Finance
Digital Media
FinTech
Manufacturing
Social Media
Financial Services
Franchise
Non Profit
Mobile Advertising
Internet
Android
Impact
Biotech
Proptech
Sustainability
Hardware
Transportation
Enterprise
Community
Media (Entertainment)
Web3
Medical
Theatre
Recruiting
Any country
South Korea
Africa
Oceania
Brazil
Saudi Arabia
Singapore
LATAM
Greece
Gibraltar
Norway
Liberia
Mexico
Taiwan
Sweden
Zambia
Puerto Rico
Nigeria
Isle of Man
Tunisia
Pakistan
Romania
Russian Federation
Togo
Tajikistan
Zimbabwe
Australia
Oman
Cameroon
Colombia
India
New Zealand
China
Sri Lanka
Vietnam
Armenia
Costa Rica
Chile
Switzerland
Czech Republic
Kenya
Cayman Islands
Kuwait
Kazakhstan
Jamaica
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uganda
Turkey
Uzbekistan
Venezuela
Guatemala
Seychelles
Germany
Japan
South Africa
Egypt
France
Georgia
Denmark
Croatia
Hong Kong
Ghana
Iraq
Mali
Morocco
Myanmar
Latvia
Malaysia
Portugal
Philippines
Poland
Rwanda
Sierra Leone
Senegal
Thailand
El Salvador
Uruguay
Tanzania
United Kingdom
United States
Canada
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Cyprus
Qatar
United Arab Emirates
Spain
Angola
Europe
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Bulgaria
Ecuador
Bahrain
Bahamas
Estonia
Faroe Islands
Jersey
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Grenada
Israel
Honduras
Iceland
Cambodia
Lithuania
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Ireland
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 20 Life Science VC Funds & Investors in Austria (June 2026)

The most active venture capital funds investing in Austria Life Science startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Austria Life Science startup companies. Find investors to raise a Pre-Seed, Seed or Series A round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
XISTA Science Ventures
VC Fund
3 Austria, France, Slovenia Seed, Pre-Seed, Series A Biotechnology, Medical, Software $511k–$20M
xista science ventures
VC Fund
3 Austria, Slovenia Seed, Pre-Seed, Series A Biotechnology, Medical, Software $511k–$20M
Nina Capital
VC Fund
2 United States, United Kingdom, Germany Seed, Pre-Seed, Series A Health Care, Artificial Intelligence, Software $573k–$22M
Longevitytech.fund
VC Fund
2 United States, United Kingdom, The Netherlands Seed, Convertible Note, Pre-Seed Biotechnology, Health Care, Life Science $100k–$10M
APEX Ventures
VC Fund
2 Germany, United Kingdom, Austria Seed, Series A, Pre-Seed Artificial Intelligence, Software, Health Care $511k–$21M
R42 Group
VC Fund
2 United Kingdom, United States, Austria Seed, Pre-Seed Biotechnology, Health Care, Software $439k–$8M
SOSV
VC Fund
1 United States, India, United Kingdom Seed, Convertible Note, Pre-Seed Biotechnology, Health Care, Software
NovaCapital
VC Fund
1 Italy, Israel, Austria Seed, Series A, Pre-Seed Software, Health Care, Manufacturing $137k–$40M
Biogena
VC Fund
1 Austria, United States Seed Food and Beverage, Fitness, Health Care
Pace Ventures
VC Fund
1 United States, Germany, United Kingdom Seed, Series A Software, Biotechnology, Information Technology $2.8M–$35M
Lansdowne Investment Company Cyprus
VC Fund
1 Austria Seed Life Science, Biotechnology, Semiconductor
Gamma Capital Partners
VC Fund
1 Austria, United States, Germany Series A, Seed Software, Manufacturing, Information Technology $406k–$8M
Axilium Holding
VC Fund
1 Sweden, Austria Seed FinTech, Oncology, Software $450k–$7.8M
Polaris Partners
VC Fund
1 United States, Ireland, Singapore Series B, Series A, Series C Biotechnology, Health Care, Medical $4.5M–$107M
HCVC
VC Fund
1 United States, France, United Kingdom Seed, Series A, Pre-Seed Software, Artificial Intelligence, Robotics $920k–$30M
OrbiMed
VC Fund
1 United States, China, Israel Series B, Series A, Series C Biotechnology, Health Care, Medical $10M–$150M
The Austrian Research Promotion Agency (FFG)
VC Fund
1 Austria, United States, Belgium Grant, Seed, Pre-Seed Software, Artificial Intelligence, Medical $67k–$3.5M
tecnet equity
VC Fund
1 Austria Seed, Series A Software, SaaS, Biotechnology $400k–$6M
FastVentures
VC Fund
1 Hungary, South Korea, United States Seed, Series A, Series B Software, Biotechnology, Information Technology $424k–$31M
Gateway Ventures
VC Fund
1 Germany, Austria, Estonia Seed, Series A Software, Information Technology, Apps $1.6M–$11M
Access all 33 VC funds in Austria Life Science startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

XISTA Science Ventures
VC Fund · Klosterneuburg, Niederosterreich, Austria · 3 investments in Austria Life Science startups

We invest in deep tech startups and academic spin-offs with a strong innovation based on science, engineering and technology. We invest as lead investor in pre-seed and seed stages and have the ability to follow on in later rounds. We understand the needs of science and tech based startups and offer tailored support for entrepreneurs. We areembedded in the venture capital scene, yet understand the language of science and the world of research. Thanks to our diverse team, our expertise and experience in technology, entrepreneurship, finance, legal, IP, and strategic consulting will support your startup right from the start.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Software
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Austria, France, Slovenia

Investor stats

  • Total investments: 33
  • Round size: Seed $576k–$5.9M; Pre-Seed $511k–$1.4M; Series A $5.2M–$20M
  • Lead/follow: 61% lead, 39% follow

Portfolio highlights

  • Rivus Batteries — Rivus is a start-up that serves as the commercialization platform for the aqueous organic flow battery technology.
  • Factorymaker — Factorymaker designs and analyzes sustainable, cost-efficient industrial layout and building proposals, guiding you through informed decisions at early design stage
  • VALANX Biotech — VALANX Biotech is a site-specific protein conjugation platform to enable fast and cost efficient protein-drug-conjugates development.
Show all investments...

xista science ventures
VC Fund · Klosterneuburg, Niederosterreich, Austria · 3 investments in Austria Life Science startups

We invest in deep tech startups and academic spin-offs with a strong innovation based on science, engineering and technology. We invest as lead investor in pre-seed and seed stages and have the ability to follow on in later rounds. We understand the needs of science and tech based startups and offer tailored support for entrepreneurs. We areembedded in the venture capital scene, yet understand the language of science and the world of research. Thanks to our diverse team, our expertise and experience in technology, entrepreneurship, finance, legal, IP, and strategic consulting will support your startup right from the start.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Software
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Austria, Slovenia

Investor stats

  • Total investments: 22
  • Round size: Seed $1.8M–$7.8M; Pre-Seed $511k–$1.4M; Series A $5.2M–$20M
  • Lead/follow: 64% lead, 36% follow

Portfolio highlights

  • subdron — subdron turns the seabed from a blind spot into a monitored domain.
  • infrared.city — Redefine environmental simulations. Our bespoke AI models revolutionise performative design, slashing time, cost, and complexity. Access cutting-edge services effortlessly because innovation should be for everyone
  • VALANX Biotech — VALANX Biotech is a site-specific protein conjugation platform to enable fast and cost efficient protein-drug-conjugates development.
Show all investments...

Nina Capital
VC Fund · Barcelona, Catalonia, Spain · 2 investments in Austria Life Science startups, 10 in the past 12 months

We deploy early stage capital to fuel the growth of need-driven health technology companies.

Show more...

Investment focus

  • Industry: Health Care, Artificial Intelligence, Software
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, United Kingdom, Germany

Investor stats

  • Total investments: 85
  • Round size: Seed $2M–$5.2M; Pre-Seed $573k–$2.4M; Series A $5M–$22M
  • Lead/follow: 41% lead, 59% follow
  • Last fund: Likely actively investing — fund raised in 2025

Portfolio highlights

  • Navidence — Navidence provides a transformative Real World Evidence (RWE) Design platform that enables organizations to efficiently adapt to the ever-increasing ecosystem of Real World Data (RWD) sources. The company unlocks the power of Computable Operational Definitions (CODefs) for RWE Design and RWD Assessment. Navidence's RWE Sherpa platform offerstools to streamline the process of defining an RWE study's data, making it easier for researchers to conduct their studies in the age of data.
  • Rivia — Integrated Clinical Trial Intelligence. Drive therapeutic evaluation and trial management with real-time insights.
  • Sober Sidekick — Gamified peer to peer support
Show all investments...

Longevitytech.fund
VC Fund · Prague, Hlavni mesto Praha, Czech Republic · 2 investments in Austria Life Science startups

Investing globally in technologies extending healthy lifespans

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Life Science
  • Stage:Seed, Convertible Note, Pre-Seed
  • Geography: United States, United Kingdom, The Netherlands

Investor stats

  • Total investments: 49
  • Round size: Seed $1.7M–$10M; Pre-Seed $100k–$3.2M
  • Lead/follow: 31% lead, 69% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • Whytics — DAGI: higher-level causal models from spatiotemporal coarse‑graining Whytics builds tools to reveal and validate macro‑causal structure—the stable, higher-level variables that appear when many parts of a system interact across space and time.
  • Klothea Bio — Klothea Bio is a protein well known for its powerful anti-aging capabilities, such as tumor suppression, neuroprotection, and antioxidative actions. As people age, their klotho levels drop to harmful levels. The metabolic disease syndrome will be the focus of the first investigations, while later studies will try to extend therapeutic applicationsto cancer, Alzheimer's disease, obesity, and other age-related diseases.
  • Yuva Biosciences — Using cutting edge mitochondrial science to develop cosmeceuticals and pharmaceuticals.
Show all investments...

APEX Ventures
VC Fund · Vienna, Wien, Austria · 2 investments in Austria Life Science startups

APEX Ventures is a deep-tech and medical-focused venture capital firm.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Health Care
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Germany, United Kingdom, Austria

Investor stats

  • Total investments: 53
  • Round size: Seed $1.3M–$8M; Pre-Seed $511k–$3M; Series A $2.2M–$21M
  • Lead/follow: 32% lead, 68% follow
  • Last fund: May invest from a new fund soon — last raise in 2020

Portfolio highlights

  • GEMESYS — Gemesys creates a chip that functions similarly to the human brain in order to overcome processing constraints and empower AI with the hardware it needs to complete its destiny
  • HyperHeat — HyperHeat is building a cutting-edge, all-electric heating solution designed to reach temperatures of up to 2,000°C. Using renewable electricity HyperHeat is providing an efficient alternative to fossil fuel combustion. With an efficiency rate of up to 98%, HyperHeat is ideal for retrofitting industrial processes, enabling significant CO2reductions across industries like steel, cement, and chemicals. The scalable technology offers a cost-efficient approach to decarbonizing thermal processes, with a potential to reduce global CO2 emissions by over 4.5 gigatons annually.
  • TriLite Technologies — The world's smallest projection displays from TriLite take laser beam scanning technology to the next level, for augmented vision as light as the eyewear of today.
Show all investments...

R42 Group
VC Fund · Stanford, California, United States · 2 investments in Austria Life Science startups

R42 Group is a venture fund and an institute which invents, invests and informs covering AI, deep science, 5G mobile, biotech and fintech.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Pre-Seed
  • Geography: United Kingdom, United States, Austria

Investor stats

  • Total investments: 30
  • Round size: Seed $654k–$8M; Pre-Seed $439k–$2M
  • Lead/follow: 30% lead, 70% follow

Portfolio highlights

  • Healx — At Healx we use AI drug discovery to develop new treatments for rare diseases. We bring treatments from prediction to patient.
  • Stamp Free — stampfree.ai Digital Shipping Solutions enables customers to send parcels and returns with just a phone conveniently and securely.
  • WiseWorks — AI-Powered Communications Intelligence for Financial Institutions
Show all investments...

SOSV
VC Fund · Princeton, New Jersey, United States · 1 investments in Austria Life Science startups, 75 in the past 12 months

SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Convertible Note, Pre-Seed
  • Geography: United States, India, United Kingdom

Investor stats

  • Total investments: 1482
  • Lead/follow: no public data

Portfolio highlights

  • MixRift — MIXRIFT - game developers specialized in Mixed Reality
  • unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
  • Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
Show all investments...

NovaCapital
VC Fund · Milano, Lombardia, Italy · 1 investments in Austria Life Science startups

NovaCapital invests in the union between entrepreneurs and innovation. It offers international and managerial experience, to transform innovative start-ups and already established companies into structured companies, with managerial skills and an international network.

Show more...

Investment focus

  • Industry: Software, Health Care, Manufacturing
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Italy, Israel, Austria

Investor stats

  • Total investments: 15
  • Round size: Seed $1.3M–$40M; Pre-Seed $137k–$140k; Series A $5.5M–$22M
  • Lead/follow: 20% lead, 80% follow

Portfolio highlights

  • ISAAC — ISAAC is an innovative tech company at the forefront of enhancing structural resilience through advanced active mass damper systems. Specializing in seismic and wind protection, ISAAC's solutions dynamically improve the stability of existing buildings and infrastructure. Utilizing non-invasive retrofitting techniques, our active mass dampersenhance the safety and comfort of structures under dynamic loads without altering their original aesthetics. This approach not only safeguards buildings during natural events but also contributes to greener construction practices by avoiding extensive reconstruction, aligning with sustainable development goals in urban environments.
  • Kiutra — We provide cryogen-free cooling systems that simplify low-temperature research. Our solutions offer fast cooldowns, automated control and millikelvin performance ideal for quantum technologies and material science.
  • Juniper Biosciences — Juniper Biosciences are at the forefront of transforming healthcare with revolutionary radiopharmaceuticals.
Show all investments...

Biogena
VC Fund · Salzburg, Salzburg, Austria · 1 investments in Austria Life Science startups

Biogena develops, produces & markets high-quality dietary supplements.

Show more...

Investment focus

  • Industry: Food and Beverage, Fitness, Health Care
  • Stage:Seed
  • Geography: Austria, United States

Investor stats

  • Total investments: 3
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • NEOH USA — NEOH USA is a fast growing new food brand from Kirkland, WA and the leader in Crossbars. It satisfies your sweet tooth without the guilt. Crossbars taste as great as a candy bars but are protein bars.
  • Saturo — Eine Flasche Saturo = eine vollwertige Mahlzeit mit 36 g Protein und 26 Vitaminen & Mineralstoffen. Ohne zugesetzten Zucker. Jetzt probieren.
  • Luminous Labs GmbH — Welcome to Luminous Labs - we are one of the leading photobiomodulation and red light therapy companies in Europe. With a strong focus on research and development we are expanding the human health-span with our non-invasive technology. One photon at a time, starting with female fertility and longevity.
Show all investments...

Pace Ventures
VC Fund · Berlin, Berlin, Germany · 1 investments in Austria Life Science startups

Investing at the intersection of climate and health.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Information Technology
  • Stage:Seed, Series A
  • Geography: United States, Germany, United Kingdom

Investor stats

  • Total investments: 17
  • Round size: Seed $2.8M–$13M; Series A $8M–$35M
  • Lead/follow: 18% lead, 82% follow

Portfolio highlights

  • Neurable — Neurable develops software to understand human intent by using advanced machine learning techniques to classify the electrical signals produced by your brain. Neurable's software turns these biometric signals into actionable insights for measuring emotion and providing control of connected devices.
  • Metri Bio
  • Ternary Therapeutics — Ternary Therapeutics is a biotechnology research center that specializes in bioinformatics and medicinal chemistry services.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Lansdowne Investment Company Cyprus
VC Fund · 1 investments in Austria Life Science startups

Lansdowne Investment Company Cyprus

Show more...

Investment focus

  • Industry: Life Science, Biotechnology, Semiconductor
  • Stage:Seed
  • Geography: Austria

Investor stats

  • Total investments: 1
  • Lead/follow: 100% lead, 0% follow

Portfolio highlights

  • Sarcura — Sarcura GmbH is an Austrian deep-tech startup developing an instrument platform for the industrial manufacturing of advanced cell therapies. Our platform combines silicon chip technology and microfluidic processing to enable real-time process control and manipulation on a cellular level, enabling a fully automated and modular manufacturing system..
Show all investments...

Gamma Capital Partners
VC Fund · Vienna, Wien, Austria · 1 investments in Austria Life Science startups

gcp gamma capital partners is an independent Venture Capital investment firm, focused on financing dynamic technology companies in Austria, Germany, Switzerland and CEE countries.They seek to achieve superior returns by finding assets with substantial potential in their regional and sectoral focus areas, before they appear on the radar screenof mainstream players in terms of stage and/or initial investment size.

Show more...

Investment focus

  • Industry: Software, Manufacturing, Information Technology
  • Stage:Series A, Seed
  • Geography: Austria, United States, Germany

Investor stats

  • Total investments: 29
  • Round size: Seed $406k–$636k; Series A $1.3M–$8M
  • Lead/follow: 21% lead, 79% follow

Portfolio highlights

  • Icomasoft — Icomasoft ag is a Swiss pioneer of agent-less software solutions providing unprecedented transparency across your virtual and physical IT infrastructure in heterogeneous datacenters.IcomasoftÂ:registered: software solutions collect essential information for mission-critical and business-critical decisions and provide simplified, automated tasksthat support administrators, IT managers and Executives to easily and confidently analyze, plan and optimize their IT capacity. icomasoftÂ:registered: software solutions are vital for your datacenter clarity.
  • Henn GmbH & Co KG — Henn GmbH & Co KG develops and commercializes rapid connecting systems for hoses in automotive engine blocks.
  • CNSystems Medizintechnik — CNSystems Medizintechnik sells, manufactures, and develops equipment for non-invasive, continuous monitoring of blood pressure and other essential vital parameters. The company was founded in May 1998 as a spin-off from the Medical University and University of Technology Graz, Austria.
Show all investments...

Axilium Holding
VC Fund · 1 investments in Austria Life Science startups

Axilium Holding

Show more...

Investment focus

  • Industry: FinTech, Oncology, Software
  • Stage:Seed
  • Geography: Sweden, Austria

Investor stats

  • Total investments: 2
  • Round size: Seed $450k–$7.8M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Sarcura — Sarcura GmbH is an Austrian deep-tech startup developing an instrument platform for the industrial manufacturing of advanced cell therapies. Our platform combines silicon chip technology and microfluidic processing to enable real-time process control and manipulation on a cellular level, enabling a fully automated and modular manufacturing system..
  • WorkNode — Worknode is shaping the future of work. With modern technology and a deep understanding of labor market dynamics, we make flexible work safe, simple, and sustainable for both individuals and companies.For individuals, Worknode enables earning and getting paid like an employee without starting a company. For businesses, we provide a digitalemployer-of-record service that streamlines the management of external talent with full compliance, transparency, and efficiency.By building the digital infrastructure for a more flexible workforce, Worknode creates new opportunities for people to shape their careers and for companies to scale with the right skills at the right time. More than a platform, Worknode is a partner in driving a modern, dynamic, and inclusive way of working.
Show all investments...

Polaris Partners
VC Fund · Boston, Massachusetts, United States · 1 investments in Austria Life Science startups

Polaris Partners invests in healthcare and biotechnology companies. Their healthcare portfolio companies' care delivery models include digital health, consumer-centric businesses, patient-provider solutions, data science, and analytics. Their life sciences and biotechnology portfolio companies focus on molecules and platforms, therapeutics,and genomics.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series A, Series C
  • Geography: United States, Ireland, Singapore

Investor stats

  • Total investments: 450
  • Round size: Series A $4.5M–$80M; Series B $7M–$107M; Series C $10M–$100M
  • Lead/follow: 27% lead, 73% follow
  • Last fund: May invest from a new fund soon — raised $182M in 1998

Portfolio highlights

  • Thirty Madison — Thirty Madison is a human-first healthcare company, powering access to affordable specialized healthcare through brands like Keeps and Cove.
  • CliQr Technologies — CliQr is a leading provider of application-defined cloud management solutions. Offering full lifecycle management delivered in a single, intuitive packaged platform, CliQr enables businesses to easily and efficiently model, deploy and manage one to many applications, users, and clouds.CliQr’s application-defined technology de-couplesapplications from the complexity of hybrid cloud environments, allowing them to securely move, deploy and manage new and existing application across any physical, virtual or cloud environment.CliQr’s patented and patent-pending technology and its global partners help dozens of leading brands in healthcare, manufacturing and technology markets manage their cloud application lifecycles in over 15 different data center, private and public cloud environments.Headquartered in San Jose, California, with locations in Canada, India and Czech Republic, CliQr is backed by Polaris Partners, Foundation Capital, Google Ventures and TransLink Capital. For additional information, visit www.cliqr.com.
  • Invivyd — Adagio is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company’s portfolio of antibodies has been optimized using Adimab’s industry-leading antibody engineering capabilities and is designed to provide patientsand clinicians with a powerful combination of potency, breadth, durable protection (via half-life extension), manufacturability and affordability. Adagio’s portfolio of SARS-CoV-2 antibodies includes multiple, non-competing broadly neutralizing antibodies with distinct binding epitopes, led by ADG20. Adagio has secured manufacturing capacity for the production of ADG20 with thirdparty contract manufacturers through the completion of clinical trials and, if approved by regulatory authorities, through initial commercial launch.
Show all investments...

HCVC
VC Fund · Paris, Ile-de-France, France · 1 investments in Austria Life Science startups

HCVC is an early-stage Venture Capital firm backing hardtech companies worldwide. Beyond its fund, HCVC supports hardtech founders through Hardware Club, a selective global community of 500+ startups with dedicated resources, partnerships and events.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Robotics
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, France, United Kingdom

Investor stats

  • Total investments: 92
  • Round size: Seed $920k–$11M; Pre-Seed $1.4M–$5.2M; Series A $5.2M–$30M
  • Lead/follow: 23% lead, 77% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • Chiral — Next-generation electronics with nanomaterials
  • Norbert Health — Norbert Health develops a home medical pod that monitors the health of families using contactless sensors. Their product senses key vital signs including heart rate, breathing rate, and temperature, providing a real-time and historical view of the user's health. It was founded in 2019 and headquartered in Brooklyn, New York.
  • Renaissance Fusion — Renaissance Fusion is a high-temperature superconductor and stellarator company.
Show all investments...

OrbiMed
VC Fund · New York, New York, United States · 1 investments in Austria Life Science startups

Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series A, Series C
  • Geography: United States, China, Israel

Investor stats

  • Total investments: 589
  • Round size: Series A $10M–$116M; Series B $24M–$150M; Series C $15M–$143M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: Likely actively investing — fund raised in 2025

Portfolio highlights

  • Sonendo — Sonendo developing innovative technologies to transform dentistry by Saving Teeth Through Sound Science®. The GentleWave® System shows significant improvements in clinical efficacy and practice efficiency when compared to standard root canal treatment.1,2, 3 Sonendo is the parent company of TDO® Software, the developer of the most widely usedendodontic practice management software in the world, designed to simplify practice workflow. TDO software seamlessly integrates practice management, imaging, social media, referral reporting, CBCT imaging, and offers built-in communication with the GentleWave System.
  • Crown Bioscience — Crown Bioscience is an expert preclinical contract research organization providing oncology services and preclinical cancer models for drug development. Crown Biocience brings clarity to drug discovery worldwide, helping companies solve today's most pressing problems in immuno-oncology, oncology, cardiovascular, and metabolic diseases.
  • Aspen Neuroscience — personalized cell therapy Starts with you Learn More about our technology
Show all investments...

The Austrian Research Promotion Agency (FFG)
VC Fund · Vienna, Wien, Austria · 1 investments in Austria Life Science startups

The Austrian Research Promotion Agency (FFG) is the national funding agency for industrial research and development in Austria. As a "one-stop shop" offering a diversified and targeted programme portfolio, the FFG gives Austrian businesses and research facilities quick and uncomplicated access to research funding.The FFG was foundedon 1 September 2004 (pursuant to the FFG Act on establishing a research promotion agency, Federal Law Gazette I No. 73/2004). The FFG is wholly owned by the Republic of Austria, represented by the Federal Ministry for Transport, Innovation and Technology (bmvit) and the Federal Ministry of Science, Research and Economy (BMWFW). As a provider of funding services, however, the FFG also works for other national and international institutions.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Medical
  • Stage:Grant, Seed, Pre-Seed
  • Geography: Austria, United States, Belgium

Investor stats

  • Total investments: 70
  • Round size: Seed $300k–$2.2M; Grant $67k–$3.5M; Pre-Seed $480k–$1.9M
  • Lead/follow: 27% lead, 73% follow

Portfolio highlights

  • OPTIMUSE — Optimuse provides an AI-based solution that supports the pre-design phase of building renovation. The platform converts building data into a digital twin to create accurate models for planning. It integrates data such as room types, thermal properties, and HVAC systems. The system runs energy simulations to calculate heating, cooling, lighting, andequipment needs. It helps design technical systems by defining the quantity, sizing, and configuration of components. The platform develops renovation plans by modeling financial, energy, and emissions outcomes. It also offers tools for cost calculation, performance monitoring, and collaboration across project teams.
  • sequestra — Sequestra is developing a technology platform that allows for permanent binding of CO₂ in industrial residues such as steel slag, incineration ash, and demolition waste while making the carbonated materials usable for construction applications.
  • Another Earth — Another Earth is building an AI-powered simulation and synthetic data platform for Earth Observation. As our planet changes, AI models need scalable, high-quality training data to keep pace. Another Earth provides synthetic data, scenario simulations and predictions required to accelerate AI development, and enable faster, smarterdecision-making—enabling smarter decisions for a more resilient world.
Show all investments...

tecnet equity
VC Fund · Sankt Polten, Niederosterreich, Austria · 1 investments in Austria Life Science startups

tecnet equity is an Austrian venture capital fund investing in innovative high-tech companies with potential for significant growth.

Show more...

Investment focus

  • Industry: Software, SaaS, Biotechnology
  • Stage:Seed, Series A
  • Geography: Austria

Investor stats

  • Total investments: 62
  • Round size: Seed $400k–$2.5M; Series A $583k–$6M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: May invest from a new fund soon — last raise in 2009

Portfolio highlights

  • eyeson — eyeson is a leader in cloud-based video conferencing with managed multipoint video processing technology at a scale. Based on its patented single stream technology, eyeson provides API video services to easily integrate video collaboration in business workflows for full customer engagement. eyeson is managing the cloud capacity, scalable videocoding performance and data management for the customer. Based on WebRTC technology, eyeson provides browser-based video meeting integrations on all desktop and mobile devices. eyeson offers B2B focused products used by Forbes 500 companies and named by Gartner as "cool vendor in unified communications."
  • Sipfront — Sipfront helps telecom operators to deliver better services by automating 24/7 active monitoring and by providing a test framework to simulate customer calls at scale
  • Greenwood-Power — Greenwood-Power is the leading innovator for non-conventional transformers. Let's talk about your individual requirements - CONTACT US TODAY!
Show all investments...

FastVentures
VC Fund · Budapest, Budapest, Hungary · 1 investments in Austria Life Science startups

venture capital

Show more...

Investment focus

  • Industry: Software, Biotechnology, Information Technology
  • Stage:Seed, Series A, Series B
  • Geography: Hungary, South Korea, United States

Investor stats

  • Total investments: 26
  • Round size: Seed $424k–$31M; Series A $1.3M–$2.3M
  • Lead/follow: 27% lead, 73% follow

Portfolio highlights

  • Iskra — Iskra offers web3 gaming opportunities using blockchain and rewards its stakeholders based on their participation.
  • On Vacation — On Vacation is a chat-based concierge service where customers may get help making reservations and getting personalized and optimal tours from travel specialists.
  • NextChapter — NextChapter is a digital commerce platform that acquires and operates Coupang and Naver-based online native brands in Korea. NextChapter is backed by BlueRun Ventures/BRV Capital Management, Goodwater Capital, Klim Ventures, Fast Ventures and Sandbox Network.NextChapter was founded in 2021 by Joshua Kwon and Jay Chung and is headquarteredin Seoul, Korea.
Show all investments...

Gateway Ventures
VC Fund · Vienna, Wien, Austria · 1 investments in Austria Life Science startups

Gateway Ventures is Austria's biggest network of startup investors with currently over 4000 investors. We foster the Austrian and European startup eco-system by connecting investors and startups. Our startup portfolio covers FinTech, CleanTech, HeathTech, IT & Software, Big Data & Social Impact. We have financed >40 startups withseed fundings over € 30M+Gateway Ventures was founded in December 2015. Over 1000 investors and 200 partners are currently participating in the network, including European incubators, accelerators and VCs.https://www.gateway.ventures

Show more...

Investment focus

  • Industry: Software, Information Technology, Apps
  • Stage:Seed, Series A
  • Geography: Germany, Austria, Estonia

Investor stats

  • Total investments: 23
  • Round size: Seed $1.6M–$4.5M; Series A $6M–$11M
  • Lead/follow: 9% lead, 91% follow

Portfolio highlights

  • hypt — hypt is a Swiss based SaaS marketing solution that empowers companies to digitalize word-of-mouth. By using our word-of-mouth manager companies are able to activate 40% of their customers to send out a personal recommendation to their peers increasing sales through word-of-mouth by 4 times. Our solution empowers our ICP customers in the finance andinsurance segments to strategically use and optimize the most authentic and cost effective advertising channel – word-of-mouth – and makes it an accessible asset of every marketing mix.
  • LipoCheck — LipoCheck is a healthtech startup that focuses on improving the diagnosis and treatment of lipedema, a condition that affects millions of women. The company offers a digital platform that serves as a support system for patients and treating physicians. LipoCheck's services include helping patients recognize lipedema and providing assistance inbecoming symptom-free. The platform was developed with the experiences of practicing doctors, product managers, and software developers. In addition to its digital services, LipoCheck also offers a range of merchandise including hoodies and shirts.
  • vitrealab — Enlighten. Your perspective. Light Engines for AR glasses.
Show all investments...

Life Science VC funding in Austria at a glance

Stats across 23 deals from 33 investors.

33
investors
in Austria Life Science startups
23
deals
in Austria Life Science startups
$2.7M
median round
in Austria Life Science startups
48%
lead investors
lead at least one round
35%
Seed
most common funding stage

Access all 33 VC funds in Austria Life Science startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Life Science VC Funds in Austria investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 33 VC funds investing in Austria Life Science startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists